Philipp S Goerttler

Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F

H. Heimpel, G. Meinhardt, H. Pahl, 2007, Annals of Hematology.

The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera

R. Levine, H. Cario, H. Pahl, 2005, British journal of haematology.

The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.

H. Heimpel, M. Griesshammer, H. Pahl, 2005, Blood.